IC

Ikarian Capital Portfolio holdings

AUM $494M
1-Year Est. Return 153.64%
This Quarter Est. Return
1 Year Est. Return
+153.64%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$494M
AUM Growth
+$192M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
157
New
Increased
Reduced
Closed

Top Buys

1 +$53M
2 +$33.4M
3 +$27.2M
4
PTCT icon
PTC Therapeutics
PTCT
+$17.2M
5
RAPT icon
RAPT Therapeutics
RAPT
+$15.9M

Top Sells

1 +$21.6M
2 +$18.5M
3 +$17.9M
4
COGT icon
Cogent Biosciences
COGT
+$14.7M
5
VRNA
Verona Pharma
VRNA
+$13.9M

Sector Composition

1 Healthcare 99.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GMAB icon
1
Genmab
GMAB
$19.7B
$53M 5.35%
+175,000
ABVX
2
Abivax
ABVX
$8.54B
$33.4M 3.37%
+396,098
IONS icon
3
Ionis Pharmaceuticals
IONS
$13.2B
$27.2M 2.74%
+415,163
CDTX icon
4
Cidara Therapeutics
CDTX
$6.93B
$26.6M 2.69%
277,704
-186,784
MAZE
5
Maze Therapeutics
MAZE
$2.05B
$19.2M 1.94%
740,825
+478,085
PTCT icon
6
PTC Therapeutics
PTCT
$6.25B
$17.2M 1.74%
+280,551
RAPT icon
7
RAPT Therapeutics
RAPT
$953M
$15.9M 1.6%
+615,000
DNTH icon
8
Dianthus Therapeutics
DNTH
$1.93B
$13.6M 1.37%
+346,001
CYTK icon
9
Cytokinetics
CYTK
$8.16B
$12.2M 1.24%
222,674
-10,790
FULC icon
10
Fulcrum Therapeutics
FULC
$481M
$11.9M 1.2%
1,289,225
+860,704
PCVX icon
11
Vaxcyte
PCVX
$6.06B
$11.2M 1.13%
311,682
+6,682
CTMX icon
12
CytomX Therapeutics
CTMX
$693M
$10.8M 1.09%
+3,372,616
JAZZ icon
13
Jazz Pharmaceuticals
JAZZ
$10.1B
$10.3M 1.04%
77,800
+37,800
APLS icon
14
Apellis Pharmaceuticals
APLS
$2.79B
$10.2M 1.03%
451,902
+376,902
CGON icon
15
CG Oncology
CGON
$3.63B
$10M 1.01%
249,473
+94,473
AKRO icon
16
Akero Therapeutics
AKRO
$4.49B
$9.82M 0.99%
206,854
-13,146
ZURA icon
17
Zura Bio
ZURA
$252M
$9.23M 0.93%
+2,132,322
TENX icon
18
Tenax Therapeutics
TENX
$58.3M
$7.36M 0.74%
+967,600
KOD icon
19
Kodiak Sciences
KOD
$1.3B
$6.77M 0.68%
413,841
-185,693
TGTX icon
20
TG Therapeutics
TGTX
$4.99B
$6.32M 0.64%
174,959
-34,979
ACOG
21
Alpha Cognition
ACOG
$136M
$6.16M 0.62%
946,259
+28,392
CRNX icon
22
Crinetics Pharmaceuticals
CRNX
$4.5B
$5.45M 0.55%
130,902
-302,529
VRDN icon
23
Viridian Therapeutics
VRDN
$3.1B
$5.3M 0.54%
245,518
-224,431
PHVS icon
24
Pharvaris
PHVS
$1.81B
$5.24M 0.53%
+210,165
SNDX icon
25
Syndax Pharmaceuticals
SNDX
$1.72B
$5.13M 0.52%
+333,733